Volume 7 - Issue 3 - March 2010
Feature
Review
03/04/2010
Transcatheter aortic valve implantation (TAVI) was first performed by Alain Cribier in 20021 using the balloon-expandable Cribier-Edwards valve. Soon after, the self-expandable CoreValve ReValving system (Medtronic, Inc., Minneapolis,...
Transcatheter aortic valve implantation (TAVI) was first performed by Alain Cribier in 20021 using the balloon-expandable Cribier-Edwards valve. Soon after, the self-expandable CoreValve ReValving system (Medtronic, Inc., Minneapolis,...
Transcatheter aortic valve...
03/04/2010
Vascular Disease Management
Review
03/03/2010
The Edwards-SAPIEN aortic valve (Edwards Lifesciences, Irvine, California) transapical approach was introduced into clinical practice in 2005. After feasibility studies, CE mark was obtained by the end of 2007.
The Edwards-SAPIEN aortic valve (Edwards Lifesciences, Irvine, California) transapical approach was introduced into clinical practice in 2005. After feasibility studies, CE mark was obtained by the end of 2007.
The Edwards-SAPIEN aortic valve...
03/03/2010
Vascular Disease Management
Case Report and Brief Review
03/03/2010
Persistent sciatic artery (PSA) is a rare congenital vascular anomaly that occurs when the sciatic artery fails to regress during fetal development. This failure to regress is often associated with superficial femoral artery (SFA) hypoplasia...
Persistent sciatic artery (PSA) is a rare congenital vascular anomaly that occurs when the sciatic artery fails to regress during fetal development. This failure to regress is often associated with superficial femoral artery (SFA) hypoplasia...
Persistent sciatic artery (PSA)...
03/03/2010
Vascular Disease Management
Insights
Commentary
03/03/2010
Regardless of the merit of a new medical device, it does not take long for patients or relatives to inquire about new technology that could potentially be used to their advantage.
Regardless of the merit of a new medical device, it does not take long for patients or relatives to inquire about new technology that could potentially be used to their advantage.
Regardless of the merit of a new...
03/03/2010
Vascular Disease Management
Interview
02/26/2010
CREST (Carotid Revascularization Endarterectomy versus Stent Trial) is a landmark trial which shows that endarterectomy and stenting for carotid artery stenosis appear to be comparable based on the primary endpoint of the trial: death, stroke...
CREST (Carotid Revascularization Endarterectomy versus Stent Trial) is a landmark trial which shows that endarterectomy and stenting for carotid artery stenosis appear to be comparable based on the primary endpoint of the trial: death, stroke...
CREST (Carotid Revascularization...
02/26/2010
Vascular Disease Management
Column
New Techniques
03/03/2010
Since the introduction of endovenous lasers (EVL) in the early 2000s, procedure methodologies, as well as device technologies, have evolved extensively in the endeavor to improve treatment outcomes. As each novel parameter has been studied,...
Since the introduction of endovenous lasers (EVL) in the early 2000s, procedure methodologies, as well as device technologies, have evolved extensively in the endeavor to improve treatment outcomes. As each novel parameter has been studied,...
Since the introduction of...
03/03/2010
Vascular Disease Management
